Researchers identify key compounds to resolve abnormal vascular growth in age-related macular degeneration
Findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world Boston, Mass. — A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical...